Cisbio Bioassays offer a comprehensive cellular platform to develop HTRF® ligand binding assays.

Features:
 
• Single technology and cellular platform for all GPCR assays
• Unique non-radioactive ligand binding assays
• Miniaturization down to < 10µl
• Peptidic and non-peptidic fluorescent ligands
• High Specific Binding
• Low Non-Specific Binding with HTRF technology

Tag-lite fluorescent ligands available for (Feb10):

Vasopressin/Oxytocin V2
Dopamine D2
Vasopressin/Oxytocin V1a
Vasoactive Intestinal Peptide VPAC1
Opioid Delta opioid, Kappa opioid, Mu opioid
Melanocortin MC3, MC4, MC5
Angiotensin AT1, AT2
Tachykinin NK1
Tachykinin NK2
Adrenergic Alpha1A
Adrenergic Beta2
Chemokine CXCR4
Cholecystokinin CCK1, CCK2
GABA GABA-B
Histamine H1
Bradykinin B1
Bradykinin B2
Glucagon GIPR
Bombesin BB2
Ghrelin GHSR1 A
Vasoactive Intestinal Peptide PAC1
Endothelin ETA, ETB